Takasaki Jennifer, Ansell Steven M
Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC, V5J 5J8, Canada.
Bioconjug Chem. 2006 Mar-Apr;17(2):438-50. doi: 10.1021/bc050051r.
A method for preparing protein-liposome conjugates based on micelles as intermediates was developed. Ovalbumin was thiolated with 2-IT and conjugated to the surface of micelles composed of a maleimide-derivatized active lipid and a micelle-forming lipid. These micelles were then incubated with liposomes, allowing the micelle components to exchange into the liposome bilayers. Using this technique we were able to demonstrate that it was possible to saturate the surface of the micelle with protein and use this property to control the level of conjugation. Titration of these protein-micelle conjugates into liposome solutions resulted in reproducible batches of protein-liposome conjugates. Chemical cross-linking could be observed in some cases; however, this was controllable through selection of reagent concentrations. The effects of parameters such as thiolation levels, micelle lipid composition, active lipid structure, micelle-forming lipid structure, and micelle/liposome/protein ratios were examined. The method represents a general approach to the preparation of well defined and reproducible protein-liposome-based drug formulations.
开发了一种基于胶束作为中间体制备蛋白质 - 脂质体缀合物的方法。用2 - IT将卵清蛋白巯基化,并将其缀合到由马来酰亚胺衍生化的活性脂质和胶束形成脂质组成的胶束表面。然后将这些胶束与脂质体一起孵育,使胶束成分交换到脂质体双层中。使用该技术,我们能够证明用蛋白质使胶束表面饱和并利用该性质控制缀合水平是可行的。将这些蛋白质 - 胶束缀合物滴定到脂质体溶液中可得到可重复批次的蛋白质 - 脂质体缀合物。在某些情况下可以观察到化学交联;然而,这可以通过选择试剂浓度来控制。研究了诸如巯基化水平、胶束脂质组成、活性脂质结构、胶束形成脂质结构以及胶束/脂质体/蛋白质比例等参数的影响。该方法代表了一种制备定义明确且可重复的基于蛋白质 - 脂质体的药物制剂的通用方法。